FRL directors seek loan from Amazon

The independent directors of Future Retail Ltd (FRL) have sought ₹3,500 crore from Amazon as long-term loan since the US company had objected to the sale of its small format stores. The proceeds of this sale, they say, would have been used to pay FRL lenders and prevent its debt being classified as non-performing assets (NPAs).

“Since you are objecting to the sale of small-format sales, the proceeds of which were to be used to repay lenders and thereby avoid NPA classification, please confirm that you are willing to fund this amount by Monday (January 24) through an unsecured, long-term loan, subordinated to FRL’s existing lenders or any other mutually suitable and legally acceptable structure,” three independent directors of FRL wrote to Amazon on Friday. “If you do so, FRL will use such funds in order to repay FRL’s existing lenders. Alternatively, you are also free to engage with the lenders, so that we do not fall foul of our OTR (one-time restructuring) process or obligations.” The letter has been reviewed by ET.

Untitled-2Agencies

“FRL is in need for cash infusion urgently, in order to repay its lenders,” they said.

Have Sought Fund Infusion Details

“FRL is required to pay its lenders Rs 3,500 crore by January 29, 2022, failing which it will be classified as an NPA, ” the directors wrote in the letter.

Amazon, embroiled in a legal tussle with Future over plans to sell its assets to Reliance Retail, earlier this week opposed FRL’s plans to sell its 800 small-format Easyday and Heritage stores to raise money to pay lenders to avoid defaulting on loan repayments.

The directors were responding to Amazon’s letter on Wednesday in which the US ecommerce giant had offered to help FRL address its capital crunch.

Amazon did not respond to an email seeking comment on the Friday letter.

The US company had repeatedly said in court hearings that it had lined up Samara Capital to infuse funding into the cash-strapped FRL before Future Group in August 2020 opted to sell its assets on a slump sale basis to Reliance Retail for Rs 25,000 crore.

(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Apple cancelled Jon Stewart's show, and now lawmakers want to know whether it was because of China's 'coercive tactics' thumbnail

Apple cancelled Jon Stewart’s show, and now lawmakers want to know whether it was because of China’s ‘coercive tactics’

US lawmakers are pressing Apple Inc. for information about its streaming show The Problem With Jon Stewart, which was reportedly canceled following disagreements over how to handle topics such as China. Mike Gallagher, a Republican from Wisconsin, and Raja Krishnamoorthi, a Democrat from Illinois, sent a letter to Chief Executive Officer Tim Cook about the decision
Read More
Who Accepts Bitcoin as Payment? thumbnail

Who Accepts Bitcoin as Payment?

Over the years, Bitcoin has significantly dominated the cryptocurrency market and taken the world by storm. Currently the leading and most popular digital currency, Bitcoin has become widely accepted as a legitimate source of funds by many companies. For example, topping up your Microsoft account using crypto is now possible.Yet, Microsoft isn’t the only one…
Read More
pSTAKE (PSTAKE) Trading Starts February 24 – Deposit Now thumbnail

pSTAKE (PSTAKE) Trading Starts February 24 – Deposit Now

We’re excited to announce that Kraken now supports pSTAKE! Funding and Trading You can add PSTAKE to your Kraken account by navigating to Funding, selecting the asset, and hitting Deposit. Trading will begin February 24. Here’s what you need to know: Ticker PSTAKE Tradeable against EUR, USD Price precision 4 decimal places Deposit confirmations required…
Read More
Wall Street, 'in good mood' for the new drug against COVID thumbnail

Wall Street, 'in good mood' for the new drug against COVID

Los índices bursátiles estadounidenses finalizaron la sesión al alza, luego de haber cerrado el mes de septiembre con un balance negativo, animados por la noticia de un nuevo fármaco para combatir la pandemia de COVID-19.Las operaciones del Promedio Industrial Dow Jones subieron 1.43 por ciento, a los 34 mil 326 puntos; S&P 500 avanzó 1.08…
Read More
Index Of News
Total
0
Share